HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

/PRNewswire/ -- HaemaLogiX Ltd, a clinical stage immuno-oncology biotech developing novel immunotherapies for patients with blood cancers, is pleased to...

Related Keywords

Australia ,United States ,New Zealand ,Sydney ,New South Wales ,United Kingdom ,Adelaide ,South Australia ,Otago ,San Francisco ,California ,Australian ,Smithkline Beecham ,Jane Lowe ,James Allison ,Bryce Carmine ,Bristol Myers Squibb ,Geoff Nichol ,Tasuku Honjo ,University Of Technology ,Warwick University ,Royal Australasian College Of Physicians ,Sangamo Biosciences ,Development At Medarex Inc ,Prnewswire Haemalogix Ltd ,Biomarin Pharmaceutical Inc ,Novartis ,Ir Department ,Otago University Medical School ,Haemalogix Ltd ,Us Medical Affairs ,Non Executive Director ,Logix Ltd ,Global Project ,Portfolio Management ,Medarex Inc ,Prof James Allison ,Prof Tasuku Honjo ,Nobel Prize ,Chief Medical Officer ,Senior Advisor ,Thoracic Medicine ,Christchurch New Zealand ,London United ,Royal Australasian College ,Kappa Myeloma Antigen ,Lambda Myeloma Antigen ,